How China’s adoption of IPO system proved fatal for $1.7 trillion brokerage industry — explained

China's $1.7 trillion brokerage industry faces a severe regulatory crackdown, with 8,700 investment bankers facing pay cuts and travel restrictions

Written By Fareha Naaz
Updated12 Sep 2024, 01:15 PM IST
China's brokerage industry is in turmoil due to stringent regulations affecting 8,700 investment bankers, including pay cuts and travel restrictions.
China’s brokerage industry is in turmoil due to stringent regulations affecting 8,700 investment bankers, including pay cuts and travel restrictions. (Bloomberg)

China's $1.7 trillion brokerage industry is in soup amid major regulatory crackdown on investment bankers. The latest series of harsh clampdown on investment bankers came heavily on the country’s dealmakers after state-backed brokerages recently asked many of their investment bankers to hand over their passports and seek permission before taking up any business or personal travel, reported Hindustan Times. This was in response to directives issued by the Chinese regulators.

Also Read | Trade ‘loophole’ used by China should be closed, House Democrats tell Biden

Amid President Xi Jinping’s years-long common prosperity campaign, a total of 8,700 investment bankers across 147 brokerages were forced to take big pay cuts and conform to other tightening measures. A significant number of these professionals engage in capital market activities, such as IPOs and subsequent share sales, reported Hindustan Times.

Since last month, Chinese authorities reportedly detained over three top investment bankers from different securities firms. According to sources, the regulators are screening initial public offerings (IPOs) and other capital-raising activities. There are fears that bankers could be called in for questioning at any time.

Also Read | China Banks Trim Deposit Rates to Bolster Record-Low Margins

In addition to tightening approvals for overseas trips, the brokerages issued directives to employees that they require approval if they want to resign. Furthermore, approved for business travel will be undertaken jointly with a co-worker, while activities outside pre-approved itineraries would be restricted.

These stringent regulatory measures have cast uncertainty on the future of China's brokerage industry and domestic capital market activities, which have already experienced a significant slowdown amid faltering economy.

Also Read | Majority of WTO members reject China-backed investment facilitation plan

Official figures reveal that the total revenue for securities firms in the nation reached 203.3 billion yuan in the first half of the year, marking a 9% decrease from the previous year. Besides this, Chinese companies raised a total of 76.4 billion yuan in onshore listings this year, which marks 88% slump from a peak recorded two years ago.

Transition to IPO system

This comes after China departed from a regulatory approval-based listing mechanism and adopted a registration-based IPO system last year. Consequently, the role of investment bankers has become integral as companies have to appoint qualified banks, or underwriters, as sponsors of their listings before going public.

 

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:12 Sep 2024, 01:15 PM IST
Business NewsMarketsIPOHow China’s adoption of IPO system proved fatal for $1.7 trillion brokerage industry — explained

Most Active Stocks

Tata Steel share price

155.25
03:58 PM | 16 OCT 2024
-0.4 (-0.26%)

Tata Power share price

460.35
03:58 PM | 16 OCT 2024
-3.15 (-0.68%)

Bharat Petroleum Corporation share price

350.85
03:57 PM | 16 OCT 2024
1.65 (0.47%)

Bharat Electronics share price

285.65
03:49 PM | 16 OCT 2024
-3.15 (-1.09%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Coforge share price

7,120.75
10:51 AM | 7 OCT 2024
-2.4 (-0.03%)

Vijaya Diagnostic Centre share price

984.80
10:51 AM | 7 OCT 2024
-4.15 (-0.42%)

Dr. Lal Pathlabs share price

3,408.00
10:50 AM | 7 OCT 2024
-86.25 (-2.47%)
More from 52 Week High

Bombay Burmah Trading Corporation share price

2,519.95
10:51 AM | 7 OCT 2024
-245.3 (-8.87%)

Jubilant Ingrevia share price

728.55
10:51 AM | 7 OCT 2024
-65.7 (-8.27%)

Triveni Engineering & Indus share price

426.65
10:51 AM | 7 OCT 2024
-35.75 (-7.73%)

Vodafone Idea share price

9.08
10:51 AM | 7 OCT 2024
-0.72 (-7.35%)
More from Top Losers

Astrazeneca Pharma India share price

7,832.35
10:51 AM | 7 OCT 2024
399.85 (5.38%)

Finolex Industries share price

280.85
10:51 AM | 7 OCT 2024
9.2 (3.39%)

Macrotech Developers share price

1,206.20
10:51 AM | 7 OCT 2024
34.35 (2.93%)

JK Lakshmi Cement share price

797.60
10:51 AM | 7 OCT 2024
17.2 (2.2%)
More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      77,405.000.00
      Chennai
      77,411.000.00
      Delhi
      77,563.000.00
      Kolkata
      77,415.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00

      Popular in Markets

        HomeMarketsPremiumInstant LoanMint Shorts